on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has released a Form 8.3 disclosure regarding its stake in Spire Healthcare Group plc. As of December 5, 2025, Vanguard held 14,400,487 ordinary shares, representing a 3.58% interest in Spire Healthcare. This disclosure aligns with Rule 8.3 of the Takeover Code, addressing positions of those with over 1% stakes in relevant securities.
The document highlights Vanguard's recent activity, including a purchase of 7,002 shares at a price of 1.76 GBP per share. No derivative positions or arrangements are reported, and no additional disclosures were made regarding other dealings or agreements on securities relating to Spire Healthcare.
The disclosure, dated December 8, 2025, includes no commitments such as indemnities or stock-settled derivatives, ensuring transparency as required by the Code. Contact for further information is Shawn Acker at Vanguard.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news